Three-arm phase II trial comparing camrelizumab plus chemotherapy versus camrelizumab plus chemoradiation versus chemoradiation as preoperative treatment for locally advanced esophageal squamous cell carcinoma (NICE-2 Study).

Yang YangLi ZhuYan ChengZhichao LiuXiaoyue CaiJinchen ShaoMing ZhangJun LiuYifeng SunYin LiJun YiBentong YuHongjing JiangHezhong ChenHong YangLijie TanZhi-Gang Li

Published in: BMC cancer (2022)

ClinicalTrial.gov: NCT05043688 (August 29, 2021). The trial was prospectively registered.

Keyphrases

locally advanced
rectal cancer
clinical trial
study protocol
patients undergoing
phase iii
open label
radiation therapy
phase ii
randomized controlled trial
combination therapy
chemotherapy induced